These behavioral and epigenetic effects were blocked with either the administration of MOR antagonist or methyl donor supplementation (44), mechanistic evidence of the intricate relationships between obesity, opioid receptor activation, and dysregulated feeding behavior. This evidence concerns the gene OPRM1 and obesity due to melanocortin 4 receptor deficiency.